Key facts
- This page summarizes David Jakeman's Form 4 filing for CHIMERIX INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2022, 17:07.
David Jakeman - 04 Feb 2022 Form 4 Insider Report for CHIMERIX INC
- Reporting relationship
- Principal Accounting Officer
- Issuer ticker
- N/A
- Reported as of
- 04 Feb 2022
- Net transaction value
- -$18,355
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2022, 17:07:03 UTC
- Prior SEC filing
- 20 Jan 2022
- Next SEC filing
- 30 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Alrutz, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Jakeman filed Form 4 for CHIMERIX INC on 04 Feb 2022.
Change
- Previous filing in this sequence was filed on 20 Jan 2022.
- Current net transaction value: -$18,355.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMRX
transaction
Common Stock
Sale
- Transaction value
- $18,355
- Shares
- -3,300
- Change %
- -2.7%
- Price
- $5.56*
- Shares after
- 117,666
- Date
- 04 Feb 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 25, 2018, January 23, 2019, January 21, 2020 and January 22, 2021. The sales of the shares were made pursuant to automatic sell-to-cover arrangements adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grants of such restricted stock unit awards.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.56 to $5.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.